Global Cardiac Bio
Marker Diagnostic
Test Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2015
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com
Report
Description
Report Description
Cardiac Bio-Marker Diagnostic Test market includes the diagnostic tests used to measure
the concentration of proteins, also known as biomarkers that indicate the occurrence and
phase of cardiovascular disease (CVD). Cardiac biomarkers evaluate the heart function
and aid in identifying the complexity and severity of procedures further required to treat
the cardiovascular disease. The primary indications for cardiovascular diseases are Acute
Coronary Syndrome (ACS) which include Angina Pectoris (AP) and Acute Myocardial
Infraction (AMI) Congestive Heart Failure (CHF), Peripheral Artery Disease (PAD) and
others. The major causes of CVD are High Blood Pressure, smoking, diabetes, inadequate
exercise, stress, unhealthy diet, alcoholism, obesity and high blood cholesterol. More
than half of the cardiovascular diseases can be cured if diagnosed at the right time.
Cardiovascular diseases are one of the leading causes of deaths globally with around 35%
cardiovascular related deaths worldwide in 2013. As per WHO, 17.5 million people died
from CVDs in 2012, representing 31% of all global deaths. Of these deaths, an estimated
7.4 million were due to coronary heart disease or ACS which represent around 42% of
the cardiovascular deaths.
Browse Full Report@ http://www.futuremarketinsights.com/reports/cardiac-biomarker-diagnostic-test-market
It is also estimated that each year approximately around 17 million people die of
cardiovascular disease due to inappropriate diagnosis and it represents untapped market
opportunity for cardiac biomarker diagnostic test market.
Cardiac Bio-Marker Diagnostic Test Market: Drivers & Restraints
Report
Description
Report Description...